CSU professor receives $330,000 for cancer research
FORT COLLINS - The U.S. Department of Defense awarded $330,150 to a
Colorado State University professor to advance prostate cancer
Brian McNaughton, assistant professor in the Department of Chemistry and
the Department of Biochemistry and Molecular Biology, is one of 28
recipients of the 2009 Prostate Cancer Research Program New Investigator
Award. McNaughton plans to identify molecules that would deliver drugs
to prostate cancer cells but not healthy cells. The research could go a
long way to decrease the side effects associated with many drugs.
"In a perfect situation, a molecule would chaperone any anti-cancer drug
specifically to a prostate cancer cell and not healthy cells in the
body," explained McNaughton, in a statement about the grant.
"Unfortunately, the overwhelming majority of current methods to deliver
drugs to cells, such as prostate cancer cells, is not selective. This
means that drugs meant to impact prostate cancer cells impact healthy
cells as well. This often leads to negative side effects that limit the
dosage and therapeutic course of drugs. A significant percentage of
potential drugs are removed from FDA trials because of toxicity
associated with unwanted delivery to healthy cells."
More breaking news...
Cocktail bar designed as oasis from stress